|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-5-10
|
|
pubmed:abstractText |
Plasma homocysteine (Hcy) has been associated with an increased cardiovascular (CV) risk in patients with chronic heart failure (CHF). Thus, we investigated whether Hcy has a prognostic impact on CV events in CHF-patients with and without cardiorenal syndrome (CRS).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1874-1754
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright (c) 2008. Published by Elsevier Ireland Ltd.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
14
|
|
pubmed:volume |
141
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
32-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19181408-Adult,
pubmed-meshheading:19181408-Aged,
pubmed-meshheading:19181408-Biological Markers,
pubmed-meshheading:19181408-Cardiovascular Diseases,
pubmed-meshheading:19181408-Disease-Free Survival,
pubmed-meshheading:19181408-Female,
pubmed-meshheading:19181408-Follow-Up Studies,
pubmed-meshheading:19181408-Heart Failure,
pubmed-meshheading:19181408-Homocysteine,
pubmed-meshheading:19181408-Humans,
pubmed-meshheading:19181408-Kidney Diseases,
pubmed-meshheading:19181408-Male,
pubmed-meshheading:19181408-Middle Aged,
pubmed-meshheading:19181408-Risk Factors,
pubmed-meshheading:19181408-Syndrome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome.
|
|
pubmed:affiliation |
Swiss Cardiovascular Center, University Hospital, CH-3010 Bern, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
